Olfactory Ensheathing Glia Transplantation Combined with LASERPONCTURE® in Human Spinal Cord Injury: Results Measured by Electromyography Monitoring

Abstract

Preliminary results were measured by electromyography monitoring (electromyoscan) on three subjects suffering from spinal cord injury and who underwent a double therapy. The aim of this study was to evaluate regained voluntary activity below the injury in subjects who received a double therapy: 1) an olfactory ensheathing glia (OEG) transplantation using procedures developed by Dr. Hongyun Huang at the Xishan Hospital and Rehabilitation Centre, Beijing, China, and 2) LASERPONCTURE® developed by Albert Bohbot, Laboratoire de Recherches sur le LASERPONCTURE®, La Chapelle Montlinard, France. Materials uses were the LASERPONCTURE® device developed by Albert Bohbot; the PROCOMP5™ equipment with softwares BIOGRAPH INFINITI 5® and REHAB SUITE™; the sensors MYOSCAN-PRO™ EMG (SA9401M-50) to record muscle activity, and FLEX/PRO™-SA9309M to record skin conductance were fixed on the skin. An infrared laser, whose frequencies and power settings cannot be disclosed due to its proprietary nature, was applied after an OEG injection performed according to Dr. Hongyun Huang's procedures. Three cases, two males and one female, were selected for this study. Presentation and comments of the graphs recordings of voluntary muscle activity below the injury are provided. This preliminary study suggests that the double therapy restores some voluntary muscle activity as measured by electromyography monitoring.